Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Etienne Ruppe, PharmD, PhD (he/him/his)

Full professor
Université Paris Cité

Etienne Ruppé (PharmD, PhD) is a clinical bacteriologist. After studying Pharmacy and Medical Biology at the Universities of Tours and Paris Descartes, he worked on the development of an automated detection system for the main antibiotic resistance genes in the intestinal microbiota in the bacteriology laboratory of the Bichat-Claude Bernard Hospital (Prof. Antoine Andremont) in Paris, within the framework of the NOSOBIO project (financed in part by the OSEO investment bank). Then he was appointed Assistant Professor in the University Paris Diderot and in the bacteriology laboratory of the Bichat-Claude Bernard hospital (Prof. Antoine Andremont) in Paris. He did his PhD on the epidemiology of commensal, multidrug-resistant Enterobacterales and participated as scientific leader in the VOYAG-R project which aimed to measure the rate of acquisition of multidrug-resistant enteric bacteria during travel in tropical areas. He then left for a first post-doctoral internship in the pre-industrial demonstrator MetaGenoPolis created by Prof. Dusko Ehrlich and Prof. Joël Doré of INRA in Jouy-en-Josas. Within the framework of the European project EvoTAR, he worked on the identification of antibiotic resistance genes in the intestinal microbiota and their dynamics during various antibiotic exposures. He then did a second post-doctoral fellowship in the genomic research laboratory of the University Hospital of Geneva (Prof. Jacques Schrenzel) where he worked on the development of clinical metagenomics. With Prof. Schrenzel, he notably founded the first International Conference on Clinical Metagenomics (ICCMg) in Geneva, of which eight editions have been held to date. In 2017, he was appointed Associate Professor at the University of Paris Diderot and the Bichat-Claude Bernard Hospital, then Full Professor at the University of Paris in 2021. Since 2021, he is also co-leading the EVRest team (IAME unit, https://www.iame-research.center/) with Prof. Erick Denamur and will be deputy director of the next IAME unit for the 2025-2029 term. His area of expertise is antibiotic resistance in a global approach.

Disclosure(s): No financial relationships to disclose

Presentation(s):